Objective physical and mental markers of self ‐reported fatigue in women undergoing (neo)adjuvant chemotherapy for early‐stage breast cancer
CONCLUSIONSSerum IL‐12 merits confirmatory testing as an objective, treatment‐independent measure of fatigue in patients with early‐stage breast cancer. Cancer 2017. © 2017 The Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society.
Source: Cancer - Category: Cancer & Oncology Authors: Joanne E. Mortimer, Sarah Waliany, Christina M. Dieli ‐Conwright, Sunita K. Patel, Arti Hurria, Joseph Chao, Brian Tiep, Carolyn E. Behrendt Tags: Original Article Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Depression | Eating Disorders & Weight Management | Education | Epidemiology | Men | Menopause | Neurology | Obesity | Sleep Disorders | Sleep Medicine | Study | Women